Onconova Therapeutics (NASDAQ:ONTX) reported quarterly earnings of $0.26 per share. This is a 218.18 percent increase over losses of $(0.22) per share from the same period last year.
From Caution To Consideration: Why Analyst Is More Optimistic On Kimberly-Clark And Clorox Now
Bernstein analyst Callum Elliott upgraded the rating on the shares of Kimberly-Clark Corporation (NYSE: KMB) and Clorox Company (NYSE: CLX) to